1.
Basile M, Rumi F, Cicchetti A. Budget Impact analysis of ponatinib for the management of patients with chronic myeloid leukemia. Grhta [Internet]. 2021 Jul. 17 [cited 2024 Nov. 21];8(1):87-95. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2238